0001140361-11-014431.txt : 20110304 0001140361-11-014431.hdr.sgml : 20110304 20110304165148 ACCESSION NUMBER: 0001140361-11-014431 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110302 FILED AS OF DATE: 20110304 DATE AS OF CHANGE: 20110304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Malik Rajiv CENTRAL INDEX KEY: 0001388111 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 11665344 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE, SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN INC. CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: MYLAN LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 4 1 doc1.xml FORM 4 X0303 4 2011-03-02 0 0000069499 MYLAN INC. MYL 0001388111 Malik Rajiv 1500 CORPORATE DRIVE CANONSBURG PA 15317 0 1 0 0 EVP & Chief Operating Officer Common Stock 2011-03-03 4 M 0 6409 0 A 96691 D Common Stock 2011-03-04 4 S 0 2065 22.95 D 94626 D Employee Stock Option - Right to Buy 22.66 2011-03-02 4 A 0 80264 0 A 2021-03-02 Common Stock 80264 80264 D Restricted Stock Units 0 2011-03-02 4 A 0 28961 0 A Common Stock 28961 28961 D Restricted Stock Units 0 2011-03-03 4 M 0 6409 0 A Common Stock 6409 0 D Note that the amount of securities beneficially owned has been adjusted to reflect the current transaction as well as a reduction of 10,000 shares to correct an inadvertent overstatement of shares owned reported on a Form 4 filing on February 2, 2010. Each Form 4 filed for this reporting person during the period beginning on February 2, 2010 through July 29, 2010 incorrectly overstated by 10,000 shares the amount of securities beneficially owned following the transaction(s) reported on such Form 4. Represents the shares sold to cover the tax liability associated with the vesting of a portion of the restricted stock awards (RSUs) granted on March 3, 2010. These options vest in three equal annual installments beginning on March 2, 2012 and expire March 2, 2021. Each RSU represents the right to receive one share of Mylan Inc. common stock. The RSUs vest in three equal annual installments beginning on March 2, 2012. Each RSU represents the right to receive one share of Mylan Inc. common stock. The remainder of this award will vest equally on March 3, 2012 and 2013. /s/ Rajiv Malik 2011-03-04